Skip to main content
Premium Trial:

Request an Annual Quote

Biobase to Integrate, Co-Market Database With GNI's Cellular-Imagining Software

NEW YORK (GenomeWeb News) — Biobase will integrate its database with GNI’s cellular-imaging software and continue to develop and market the products, GNI said today.
 
Biobase will develop an interface between its databases, which are designed for gene regulation, signal transduction, and proteomics research, with GNI’s Cell Illustrator 3.0 software, which allows researchers to “create computer images and simulations of complete metabolic and gene regulatory pathways, signal transduction cascades and dynamic interactions.”
 
The combination “should provide users of the Cell Illustrator with easier access to pathway information and the ability to use the simulation function,” according to GNI.
 
It will be marketed to pharmaceutical companies, which GNI said will be able to “input their own research data, analyze gene networks with their own personal computers and carry out model analysis based on pathways.”
 
Pharmaceutical customers will be able to share research content and perform final experiments based on results from simulated tests, GNI said.
 
Biobase is headquartered in Germany. GNI is based in Tokyo.

Filed under

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.